Clinical Implications of the New York Heart Association Classification

Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction

(2017) G. Michael Felker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program

(2017) Carol A. Giffen et al.   PLoS One

Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification

(2016) Rui Providência et al.   AMERICAN JOURNAL OF CARDIOLOGY

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

(2013) Clyde W. Yancy et al.   CIRCULATION

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

(2011) William T Abraham et al.   LANCET

New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis

(2010) Aaron L. Baggish et al.   BIOMARKERS

Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients

(2010) Joseph G. Rogers et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

(2009) Christopher M. O’Connor et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION